Hypofractionated radiation therapy for prostate cancer: More food for thought from recent trial

Journal of Clinical Oncology

Volumn 32, Issue 17, 2014, Pages 1852-1853

  Vogelius, Ivan R ^a   Bentzen, Søren M ^b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RADIOTHERAPY; HIGH RISK PATIENT; HUMAN; LETTER; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

HUMANS; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84905836923     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.54.8123     Document Type: Letter

References (4)

1. Pollack A, Walker G, Horwitz EM, et al: Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol 31:3860-3868, 2013
2. Bentzen SM, Dörr W, Gahbauer R, et al: Bioeffect modeling and equieffective dose concepts in radiation oncology: Terminology, quantities and units. Radiother Oncol 105:266-268, 2012
3. Vogelius IR, Bentzen SM: Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: Bad news, good news, or no news? Int J Radiat Oncol Biol Phys 85:89-94, 2013
4. Diez P, Vogelius IS, Bentzen SM: A new method for synthesizing radiation dose-response data from multiple trials applied to prostate cancer. Int J Radiat Oncol Biol Phys 77:1066-1071, 2010